Current Report Filing (8-k)
September 28 2016 - 11:14AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): September 28, 2016
Rock Creek Pharmaceuticals, Inc.
(Exact name of registrant as specified
in its charter)
Delaware
|
|
000-15324
|
|
52-1402131
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
2040 Whitfield Avenue, Suite 300
Sarasota, Florida 34243
|
|
(Address of principal executive offices, including zip code)
|
|
|
|
844-727-0727
(Registrant’s telephone number,
including area code)
Not Applicable
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 1.03.
|
Bankruptcy or Receivership.
|
Rock Creek Pharmaceuticals,
Inc., together with its two wholly owned subsidiaries – RCP Development, Inc. and Star Tobacco, Inc. filed voluntary petitions
under Chapter 7 of the United States Bankruptcy Code in the District of Delaware on September 27, 2016.
The case numbers are
16-12120, 16-12121 and 16-12123, respectively.
Rock Creek Pharmaceuticals,
Inc. reported total assets of $35,139.15 and total liabilities of $21,300,999.35. RCP Development, Inc. reported total assets of
$31,308.57 and total liabilities of $51,956,693.87 and Star Tobacco, Inc. reported total assets of $482,289.25 and total liabilities
of $12,253,700.31.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ROCK CREEK PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
|
|
Date: September 28, 2016
|
By:
|
/s/ William L. McMahon
|
|
|
|
Name:
|
William L. McMahon
|
|
|
Title:
|
Chief Financial Officer
|
|
|
|
|
|
Rock Creek Pharmaceuticals (CE) (USOTC:RCPIQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rock Creek Pharmaceuticals (CE) (USOTC:RCPIQ)
Historical Stock Chart
From Apr 2023 to Apr 2024